Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson’s disease CS Machado, J Moreira, I Silva, AR Alfenim, V de Monte Vidal, ... Biomedicine & Pharmacotherapy 200, 119536 , 2026 2026
Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents A Carneiro, S Barreiro, CS Machado, M Pinto, D Chavarria, M Novás, ... ChemMedChem 21 (10), e70307 , 2026 2026
Tolcapone-loaded nanostructured lipid carriers for improved oral delivery M Pinto, C Machado, S Costa, V Díaz-Tomé, B Sarmento, ... International Journal of Pharmaceutics, 126969 , 2026 2026
Exploring Nano-Delivery Systems to Enhance the Edaravone Performance in Amyotrophic Lateral Sclerosis Treatment B Aguiar, AR Alfenim, CS Machado, J Moreira, M Pinto, FJ Otero-Espinar, ... International Journal of Molecular Sciences , 2025 2025 Citations: 5
Exploring nanocarriers for boosting entacapone bioavailability: a journey through system characterization and assessment of toxicity and pharmacological and 2D permeability … CS Machado, M Pinto, B Aguiar, S Costa, B Sarmento, FJ Otero Espinar, ... ACS Applied Materials & Interfaces 16 (43), 58299-58312 , 2024 2024 Citations: 8
Drug development for Alzheimer’s and Parkinson’s disease: where do we go now? L Sequeira, S Benfeito, C Fernandes, I Lima, J Peixoto, C Alves, ... Pharmaceutics 16 (6), 708 , 2024 2024 Citations: 27
Rescuing a troubled tolcapone with PEGylated PLGA nanoparticles: design, characterization, and hepatotoxicity evaluation M Pinto, CS Machado, S Barreiro, FJ Otero-Espinar, F Remião, F Borges, ... ACS Applied Materials & Interfaces 16 (17), 21522-21533 , 2024 2024 Citations: 8
MOST CITED SCHOLAR PUBLICATIONS
Drug development for Alzheimer’s and Parkinson’s disease: where do we go now? L Sequeira, S Benfeito, C Fernandes, I Lima, J Peixoto, C Alves, ... Pharmaceutics 16 (6), 708 , 2024 2024 Citations: 27
Exploring nanocarriers for boosting entacapone bioavailability: a journey through system characterization and assessment of toxicity and pharmacological and 2D permeability … CS Machado, M Pinto, B Aguiar, S Costa, B Sarmento, FJ Otero Espinar, ... ACS Applied Materials & Interfaces 16 (43), 58299-58312 , 2024 2024 Citations: 8
Rescuing a troubled tolcapone with PEGylated PLGA nanoparticles: design, characterization, and hepatotoxicity evaluation M Pinto, CS Machado, S Barreiro, FJ Otero-Espinar, F Remião, F Borges, ... ACS Applied Materials & Interfaces 16 (17), 21522-21533 , 2024 2024 Citations: 8
Exploring Nano-Delivery Systems to Enhance the Edaravone Performance in Amyotrophic Lateral Sclerosis Treatment B Aguiar, AR Alfenim, CS Machado, J Moreira, M Pinto, FJ Otero-Espinar, ... International Journal of Molecular Sciences , 2025 2025 Citations: 5
Tailoring lipid-polymer hybrid nanoparticles as smart nanocarriers for entacapone delivery for managing Parkinson’s disease CS Machado, J Moreira, I Silva, AR Alfenim, V de Monte Vidal, ... Biomedicine & Pharmacotherapy 200, 119536 , 2026 2026
Design, Synthesis, and Evaluation of Coumarin‐Rasagiline Hybrids as Multifunctional Neuroprotective Agents A Carneiro, S Barreiro, CS Machado, M Pinto, D Chavarria, M Novás, ... ChemMedChem 21 (10), e70307 , 2026 2026
Tolcapone-loaded nanostructured lipid carriers for improved oral delivery M Pinto, C Machado, S Costa, V Díaz-Tomé, B Sarmento, ... International Journal of Pharmaceutics, 126969 , 2026 2026